Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Gurgaon’s Kalosa Obs & Gynae Clinic Among First in City to own BTL Emsella for Urinary Incontinence Health
  • ADD MEDIA BUZZ Marks Five Transformative Years Business
  • kate spade New York’s grand debut: New store opens at Palladium Ahmedabad, Gujarat Lifestyle
  • Simplify Your Home Loan Planning with Piramal Finance Home Loan EMI Calculator Finance
  • Early Osteoporosis is a Sign of Vitamin D Deficiency: Top 10 Bone Specialists Share Advice Health
  • BillionE Mobility Receives India’s Largest EV Truck Delivery from Tata Motors and Expands Fleet to Accelerate EV Freight Transition Business
  • Inorbit Mall and Making The Difference – NGO Unveil Tech Lab for Specially-abled at Helen Keller School National
  • A2Z MEDICAL & SURGICAL Invitation for MASTER Franchises in District level Business

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Dr. Jyotsna Suri Leading India’s Tourism Renaissance on the Global Stage Business
  • LaVaste Unveils Its Gripping Trailer: A Thought-Provoking Film on Unclaimed Dead Bodies Business
  • Delta Autocorp Limited Announces H2 FY26 & FY26 Results Business
  • This Diwali AegisCovenant Surprises its Employees Diwali in a big way : Cars, Bikes, bonus, gifts and more Business
  • SEPC Bags Massive Rs 673 Crore SAIL Expansion Project; Reinforces Position in Industrial Infrastructure Business
  • A Precision Manufacturing Company serving Leading OEMs and Tier-1 Customers opens its IPO on June 30, 2026 Business

Recent Posts

  • India’s CNAP caller-name display goes live on 4G and 5G networks from November 1
  • Rare Earth Lifestyle Launches Neem-Led Personal Care Brand Neemyukt
  • Beyond Chai: How Tea Startup Xah Is Making Specialty Indian Tea Exciting
  • Gayatri Pariwar centenary opens in Delhi; Om Birla releases stamp in Mataji’s memory
  • Riaan Ghodawat Becomes the First Indian to Attend the Ballon d’Or

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Three Teams from IPS Academy Indore Win Awards at Smart India Hackathon 2025 Indore Lifestyle
  • Best Friends Offer Free Cancer Surgery on Sanjay Dutt’s Birthday Each Year to Needy Patients Entertainment
  • Nipun Taneja Reveals the Top Marketing Jobs AI Will Takeover in the Next 5 Years Lifestyle
  • AVP Infracon Limited CMD & CEO Mr. D. Prasanna Honoured at the Global Leadership Awards 2025, University of Oxford Business
  • Pushpa Jewellers Limited IPO Opens on June 30, 2025 Business
  • Business Mint Announces the Winners of the Nationwide Design and Architecture Awards – 2021 Business
  • Wrapcart to Launch Official Pokémon Merchandise Business
  • Amit Singh Unveils Cutting-Edge Cyber Security and Digital Forensics Lab, Equipping 300 Experts Daily Technology

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme